Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Retinoblastoma × Vincristine × Clear all

Phase

Phase 2 6 Phase 3 3 Phase NA 2 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia 5 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, T-Cell 2 Sezary Syndrome 1 Sarcoma, Ewing 1 Retinoblastoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Mycosis Fungoides 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Vincristine 1 Topotecan 1 Platinum Compounds 1 Melphalan 1 Hyperthermia, Induced 1 Etoposide 1 Drug Therapy 1 Cryotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡